CTOs on the Move

NucleusHealth

www.nucleushealth.io

 
The future of medical image management is in the cloud. Unfortunately, the farther data travels the more lag time accrues. We call this latency. Radiologists and other physicians are accustomed to receiving images at rates of 50 frames per second. When traveling across the entire United States, it may drop to 10 frames per second - much too slow for acceptable patient care. NucleusHealth™ overcomes latency via our patent-pending streaming protocols, client-side rendering techniques, modern web browser technologies, and the computing horsepower of todays phones, laptops and desktops. Diagnostic quality images come to life on displays at blazing-fast speeds. Even large ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.nucleushealth.io
  • 13280 Evening Creek Drive South Suite 110
    San Diego, CA USA 92128
  • Phone: 858.251.3400

Executives

Name Title Contact Details
Michael Blaha
Senior Director of Cloud Operations Profile

Similar Companies

SwedishAmerican Health System

SwedishAmerican Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. SwedishAmerican Health System is based in Rockford, IL. You can find more information on SwedishAmerican Health System at www.swedishamerican.org

Health Hero Network

Health Hero Network, Inc. is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Physician Health Choice

Physician Health Choice is a Corpus Christi, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III

Camtech Inc

Camtech Inc is a New Palestine, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.